You are here

molecular glue

Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B

Fierce Biotech

Wed, 10/30/24 - 08:45 pm

protein degradation

Eisai plants molecular glue SEED with $1.5B biobucks deal in neuro, oncology

Fierce Biotech

Tue, 08/6/24 - 11:14 am

Seed Therapeutics

Takeda joins hot molecular glue market with $1.2B deal

BioSpace

Thu, 05/23/24 - 11:59 am

Degron Therapeutics

Molecular glues are the latest craze in pharma research, but what are they?

Clinical Trials Arena

Thu, 03/21/24 - 06:38 pm

BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues

Fierce Biotech

Tue, 02/13/24 - 11:31 am

Bristol Myers Squibb

artificial intelligence

Roche pays $50M upfront to Monte Rosa in molecular glue deal

Fierce Biotech

Tue, 10/17/23 - 09:46 pm

protein degradation

Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck

Fierce Biotech

Wed, 04/5/23 - 10:09 am

protein degradation

'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal

Fierce Biotech

Tue, 10/4/22 - 11:04 am

Bristol Myers Squibb

molecular degraders

BMS protein degradation drug research turns to a startup to find molecular glues

MedCity News

Wed, 08/24/22 - 10:14 am

Bristol Myers Squibb

targeted protein degradation

drug development

More molecular glue: Plexium pens AbbVie pact months after Amgen deal

Endpoints

Thu, 04/28/22 - 10:59 am

targeted protein degradation

neurological disorders

Triana Raises $110M to Solve Undruggable Cancer Targets with Molecular Glue

BioSpace

Fri, 04/8/22 - 10:25 am

Triana Biomedicines

drug development

Ambagon adds $85M for molecular glues that stick to elusive protein targets

MedCity News

Fri, 01/7/22 - 10:32 am

Ambagon Therapeutics

protein targets

drug development